IGIB and the Serum Institute of India aims to make sickle cell treatment accessible to India's tribal communities, where the ...
Fred Hutch bioengineer Dr. Matthias Stephan is working to develop a special foam that could help make gene therapy for blood ...
The Oak Ridger on MSN
Can microbes thrive under industrial conditions to make biofuel?
Scientists are genetically engineering microbes to withstand industrial conditions for biofuel production. Researchers found ...
Pyrukynd, which Agios sells for a rare type of anemia, missed one of its main objectives in a study seen as crucial for its ...
Agios reported mixed results from a Phase 3 study of its drug Pyrukynd in sickle cell, raising doubts about the drug's ...
Agios Pharmaceuticals (AGIO) stock falls as a late-stage trial for its lead drug mitapivat in sickle cell disease indicate a ...
Agios Pharmaceuticals said on Wednesday its sickle cell disease drug met one of its two main goals in a late-stage study of patients aged 16 and older but failed to show a statistically significant ...
Darlaine and Dwight Carson say they both knew they carried the sickle cell trait but never imagined their daughter would have ...
Women with sickle cell disease have a significantly higher likelihood of developing preeclampsia than the general population, but a blood test could identify which patients have the greatest risk.A ...
India launched its first indigenous CRISPR-based gene therapy, 'BIRSA 101,' to combat sickle cell disease, prevalent among ...
The world-class, low-cost gene editing solution named "BIRSA 101", in honour of Bhagwan Birsa Munda, remembered as a great ...
The CRISPR Cas9 gene editing tool — the genetic scissors that won the 2020 Nobel Prize in Chemistry — is essentially based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback